title: Continued utilization and costs of proton pump inhibitors after Helicobacter pylori eradication in chronic users of gastrointestinal drugs.
authors.forename: R M
authors.initials: RM
authors.lastname: Klok
authors.forename: J R B J
authors.initials: JR
authors.lastname: Brouwers
authors.forename: P B
authors.initials: PB
authors.lastname: Van den Berg
authors.forename: L T W
authors.initials: LT
authors.lastname: De Jong-Van den Berg
authors.forename: K
authors.initials: K
authors.lastname: Tolley
authors.forename: M J
authors.initials: MJ
authors.lastname: Postma
mesh_terms: D000658:Amoxicillin / Q000191:economics / Q000627:therapeutic use; D017291:Clarithromycin / Q000191:economics / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D016208:Databases, Factual; D005765:Gastrointestinal Agents / Q000191:economics / Q000627:therapeutic use*; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D009426:Netherlands; D054328:Proton Pump Inhibitors
chemical_list: D005765:Gastrointestinal Agents; D054328:Proton Pump Inhibitors; D000658:Amoxicillin; D017291:Clarithromycin